MARKET

BIOCQ

BIOCQ

Biocept Inc
OTCPK
0.045
0.000
0.00%
Closed 09:30 12/01 EST
OPEN
--
PREV CLOSE
0.045
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
27.00
52 WEEK LOW
0.045
MARKET CAP
118.17K
P/E (TTM)
-0.0013
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at BIOCQ last week (1120-1124)?
Weekly Report · 6d ago
Weekly Report: what happened at BIOCQ last week (1113-1117)?
Weekly Report · 11/20 12:13
Weekly Report: what happened at BIOCQ last week (1106-1110)?
Weekly Report · 11/13 12:04
Weekly Report: what happened at BIOCQ last week (1030-1103)?
Weekly Report · 11/06 12:12
Weekly Report: what happened at BIOCQ last week (1023-1027)?
Weekly Report · 10/30 12:37
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 10/24 21:31
Why EngageSmart Shares Are Trading Higher By Around 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Benzinga · 10/23 17:54
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 10/23 13:06
More
About BIOCQ
Biocept, Inc. is a molecular oncology diagnostics company. The Company focuses on developing and commercializing clinical diagnostic laboratory assays designed to identify rare tumor cells and cell-free tumor deoxyribonucleic acid (DNA) from blood and cerebrospinal fluid (CSF). Its product is branded and trademarked under the name CNSide. CNSide encompasses a suite of cellular and molecular technologies intended to aid medical professionals in CSF analysis and central nervous system (CNS) disease management in patients with solid tumors. It offers and conducts its commercialized diagnostic assays, which include cell capture and enumeration, immunocytochemistry, fluorescent in situ hybridization (FISH), and next generation sequencing (NGS). It has commercialized its CNSide assays for detecting and characterizing many different carcinomas and melanoma. These assays utilize its dual cellular and ctDNA technology platforms and provide biomarker analysis from a patient’s CSF sample.

Webull offers Biocept Inc stock information, including OTCPK: BIOCQ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BIOCQ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BIOCQ stock methods without spending real money on the virtual paper trading platform.